[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SG70666A1 - Trovafloxacin mesylate tablet - Google Patents

Trovafloxacin mesylate tablet

Info

Publication number
SG70666A1
SG70666A1 SG1999000117A SG1999000117A SG70666A1 SG 70666 A1 SG70666 A1 SG 70666A1 SG 1999000117 A SG1999000117 A SG 1999000117A SG 1999000117 A SG1999000117 A SG 1999000117A SG 70666 A1 SG70666 A1 SG 70666A1
Authority
SG
Singapore
Prior art keywords
trovafloxacin mesylate
mesylate tablet
tablet
trovafloxacin
mesylate
Prior art date
Application number
SG1999000117A
Other languages
English (en)
Inventor
Alton Dale Johnson
Christopher Michael Sinko
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of SG70666A1 publication Critical patent/SG70666A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SG1999000117A 1998-01-21 1999-01-20 Trovafloxacin mesylate tablet SG70666A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7201398P 1998-01-21 1998-01-21

Publications (1)

Publication Number Publication Date
SG70666A1 true SG70666A1 (en) 2000-02-22

Family

ID=22105016

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1999000117A SG70666A1 (en) 1998-01-21 1999-01-20 Trovafloxacin mesylate tablet

Country Status (34)

Country Link
US (1) US6187341B1 (tr)
EP (1) EP0930068A3 (tr)
JP (1) JPH11269072A (tr)
KR (1) KR100314977B1 (tr)
CN (1) CN1227743A (tr)
AP (1) AP1094A (tr)
AR (1) AR012780A1 (tr)
AU (1) AU758381B2 (tr)
BG (1) BG103106A (tr)
BR (1) BR9900116A (tr)
CA (1) CA2259698C (tr)
CO (1) CO4810225A1 (tr)
DZ (1) DZ2712A1 (tr)
EA (1) EA003247B1 (tr)
GT (1) GT199900004A (tr)
HR (1) HRP990023A2 (tr)
HU (1) HUP9900154A3 (tr)
ID (1) ID23735A (tr)
IL (1) IL128051A0 (tr)
IS (1) IS4947A (tr)
MA (1) MA24747A1 (tr)
NO (1) NO990243L (tr)
NZ (1) NZ333838A (tr)
OA (1) OA10958A (tr)
PA (1) PA8466701A1 (tr)
PE (1) PE20000169A1 (tr)
PL (1) PL330981A1 (tr)
SG (1) SG70666A1 (tr)
SK (1) SK4299A3 (tr)
TN (1) TNSN99007A1 (tr)
TR (1) TR199900089A3 (tr)
TW (1) TW518224B (tr)
YU (1) YU2399A (tr)
ZA (1) ZA99393B (tr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2349161C (en) * 1998-11-10 2008-01-29 Bayer Aktiengesellschaft Pharmaceutical moxifloxacin preparation
AU1188601A (en) * 1999-09-20 2001-04-24 Alza Corporation Process for lessening polymorphic conversion of a drug
ES2231275T3 (es) * 1999-10-08 2005-05-16 Affinium Pharmaceuticals, Inc. Inhibidores de fab i.
FR2808441B1 (fr) * 2000-05-04 2004-06-18 Oreal Utilisation de fibres dans une composition de soin ou de maquillage pour matifier la peau
DE10031043A1 (de) * 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
JP4387804B2 (ja) * 2001-04-06 2009-12-24 アフィニアム・ファーマシューティカルズ・インコーポレイテッド ＦａｂＩ阻害剤
EP1396263A1 (en) 2002-08-09 2004-03-10 Warner-Lambert Company Film coating for tablets and caplets
WO2004052890A1 (en) * 2002-12-06 2004-06-24 Affinium Pharmaceuticals, Inc. Heterocyclic compounds, methods of making them and their use in therapy
CN100415284C (zh) * 2002-12-30 2008-09-03 毛友昌 六味木香片的制备方法
EP1608377B1 (en) 2003-03-17 2008-10-01 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
ES2297067T3 (es) * 2003-03-19 2008-05-01 The Jordanian Pharmaceutical Manufacturing Co. Ltd. Composiciones farmaceuticas no higroscopicas que contienen acidos quinolinacarboxilicos de hidratados.
US8906413B2 (en) 2003-05-12 2014-12-09 Supernus Pharmaceuticals, Inc. Drug formulations having reduced abuse potential
WO2005009395A2 (en) * 2003-07-23 2005-02-03 L. Perrigo Company Cellulosic fiber containing composition
WO2007053131A2 (en) 2004-06-04 2007-05-10 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as antibiotic agents
ES2531735T3 (es) * 2004-10-15 2015-03-18 Supernus Pharmaceuticals, Inc. Preparaciones farmacéuticas con menor potencial de abuso
JP2009518399A (ja) * 2005-12-05 2009-05-07 アフィニウム ファーマシューティカルズ， インク． Ｆａｂｉ阻害剤および抗菌剤としてのヘテロ環アクリルアミド化合物
US8318720B2 (en) * 2006-07-20 2012-11-27 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as Fab I inhibitors
US8263613B2 (en) * 2007-02-16 2012-09-11 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab I inhibitors
PT2861608T (pt) 2012-06-19 2019-06-28 Debiopharm Int Sa Derivados pró-fármacos de (e)-n-metil-n-((3-metilbenzofuran-2-il)metil)-3-(7-oxo-5,6,7,8-tetra-hidro-1,8-naftiridin-3-il)acrilamida
SI3419628T1 (sl) 2016-02-26 2021-03-31 Debiopharm International Sa Zdravilo za zdravljenje infekcij diabetičnega stopala

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601566A1 (de) * 1986-01-21 1987-07-23 Bayer Ag Pharmazeutische zubereitungen von ciprofloxacin
US5286754A (en) 1986-01-21 1994-02-15 Bayer Aktiengesellschaft Pharmaceutical formulations of ciprofloxacin
US4957554A (en) 1989-08-16 1990-09-18 Minnesota Mining And Manufacturing Company Dimensionally-controlled ceramics
DE4120646A1 (de) 1991-06-22 1992-12-24 Bayer Ag 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
JP3188476B2 (ja) * 1995-08-29 2001-07-16 ファイザー・インコーポレーテッド 両性イオン形トロバフロキサシン

Also Published As

Publication number Publication date
EP0930068A3 (en) 1999-12-22
NO990243D0 (no) 1999-01-20
EA003247B1 (ru) 2003-02-27
TNSN99007A1 (fr) 2005-11-10
BR9900116A (pt) 2000-05-02
TW518224B (en) 2003-01-21
HU9900154D0 (en) 1999-03-29
CO4810225A1 (es) 1999-06-30
AP1094A (en) 2002-08-19
IS4947A (is) 1999-07-22
TR199900089A2 (tr) 1999-10-21
EP0930068A2 (en) 1999-07-21
JPH11269072A (ja) 1999-10-05
NO990243L (no) 1999-07-22
HUP9900154A2 (hu) 1999-09-28
KR19990068014A (ko) 1999-08-25
BG103106A (en) 1999-08-31
MA24747A1 (fr) 1999-10-01
DZ2712A1 (fr) 2003-09-01
AU758381B2 (en) 2003-03-20
CA2259698A1 (en) 1999-07-21
PL330981A1 (en) 1999-08-02
PA8466701A1 (es) 2000-09-29
ZA99393B (en) 2000-07-21
ID23735A (id) 2000-05-11
US6187341B1 (en) 2001-02-13
IL128051A0 (en) 1999-11-30
OA10958A (en) 2001-10-31
GT199900004A (es) 2000-07-08
CA2259698C (en) 2003-04-15
SK4299A3 (en) 2000-06-12
AP9901443A0 (en) 1999-03-31
PE20000169A1 (es) 2000-03-10
HUP9900154A3 (en) 2000-12-28
CN1227743A (zh) 1999-09-08
AR012780A1 (es) 2000-11-08
AU1217399A (en) 1999-08-12
TR199900089A3 (tr) 1999-10-21
EA199900046A2 (ru) 1999-08-26
YU2399A (sh) 2002-06-19
KR100314977B1 (ko) 2001-11-24
NZ333838A (en) 2000-03-27
EA199900046A3 (ru) 1999-12-29
HRP990023A2 (en) 1999-08-31

Similar Documents

Publication Publication Date Title
AP9901443A0 (en) Trovafloxacin mesylate tablet
GB2352395B (en) Paroxetine methanesulfonate
EP1145714A4 (en) DRUGS
GB2337093B (en) Table construction
HUP0104047A3 (en) Tablet dispenser
HK1030332A2 (en) ???
AU141186S (en) Tablet
HK1042879A1 (zh) 貯片盒
GB9904419D0 (en) 4-aminoquinolines
GB9815148D0 (en) Tablet dispensers
GB9906738D0 (en) Mutagenesis
GB9828707D0 (en) Pharmaceutical uses
CA84666S (en) Pharmaceutical tablet
CA83558S (en) Pharmaceutical tablet
CA89374S (en) Tablet
CA89992S (en) Tablet
CA89993S (en) Tablet
EG22401A (en) Set 3c1-strong
CA87423S (en) Table
CA87979S (en) Eucharist table
SI1137581T1 (en) Tablet dispenser
GB9916356D0 (en) Quick hinge
GB9915559D0 (en) Slide device
AU141868S (en) Tablet
GB9807226D0 (en) Waffle